276 related articles for article (PubMed ID: 25859844)
1. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
[TBL] [Abstract][Full Text] [Related]
2. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
Xing W; Zeng C
Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
[TBL] [Abstract][Full Text] [Related]
3. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
Dai B; Zhang Y; Zhang P; Pan C; Xu C; Wan W; Wu Z; Zhang J; Zhang L
Tumour Biol; 2016 Jul; 37(7):8621-31. PubMed ID: 26733179
[TBL] [Abstract][Full Text] [Related]
6. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
[TBL] [Abstract][Full Text] [Related]
7. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
8. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
[TBL] [Abstract][Full Text] [Related]
9. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
[TBL] [Abstract][Full Text] [Related]
10. Correlation of Delta-like ligand 4 (DLL4) with VEGF and HIF-1α expression in human glioma.
Li Z; Wang J; Gong L; Wen Z; Xu C; Huang X
Asian Pac J Cancer Prev; 2011; 12(1):215-8. PubMed ID: 21517260
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
Xue H; Guo X; Han X; Yan S; Zhang J; Xu S; Li T; Guo X; Zhang P; Gao X; Liu Q; Li G
Oncotarget; 2016 Jan; 7(4):4785-805. PubMed ID: 26715733
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
Huang RQ; Shi DL; Huang W; Chen F; Lu YC
J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
[TBL] [Abstract][Full Text] [Related]
13. Deregulated expression of cry1 and cry2 in human gliomas.
Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
[TBL] [Abstract][Full Text] [Related]
14. ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.
Xiong J; Zhou L; Yang M; Lim Y; Zhu YH; Fu DL; Li ZW; Zhong JH; Xiao ZC; Zhou XF
Neuro Oncol; 2013 Aug; 15(8):990-1007. PubMed ID: 23576602
[TBL] [Abstract][Full Text] [Related]
15. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
16. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of p42.3 in low- and high-grade gliomas.
Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
[TBL] [Abstract][Full Text] [Related]
18. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
[TBL] [Abstract][Full Text] [Related]
19. Roundabout4 suppresses glioma-induced endothelial cell proliferation, migration and tube formation in vitro by inhibiting VEGR2-mediated PI3K/AKT and FAK signaling pathways.
Cai H; Xue Y; Li Z; Hu Y; Wang Z; Liu W; Li Z; Liu Y
Cell Physiol Biochem; 2015; 35(5):1689-705. PubMed ID: 25833462
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the Regulation of Roundabout4 by Hypoxia-Inducible Factor-1α in Microvascular Endothelial Cells.
Tian R; Liu Z; Zhang H; Fang X; Wang C; Qi S; Cheng Y; Su G
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2586-94. PubMed ID: 26066603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]